Validation of a novel 3D culture platform for tnbc treatment selection

Active Grant Awarded Last action

Award ID
R01CA271682
Recipient
Awarding agency
Obligated
$3,027,149

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date 84% complete
Place of performance
Houston, TX 77030, USA

Award details come from USAspending.gov.

Description

Abstract
The goal of this academic [houston methodist research institute (HMRI) and MD anderson cancer center (MDACC)] and industrial (EMPIRI) collaborative project is to validate a novel, functional cancer diagnostic assay for clinical translation to improve and personalize the care of triple-negative breast cancer (TNBC) patients. The study will validate a novel 3D tumor tissue culture method (E-SLICES) invented by MPI kyuson YUN (HMRI) and licensed to EMPIRI, INC., a biotech startup CO-founded by DR. YUN and dave gallup (MPI). Together with DR. Naoto ueno (MPI, MDACC), a renowned physician-scientist specializing in TNBC research and patient care, the team will validate the predictive accuracy of E-SLICES for individual TNBC patient responses to recently approved chemoimmunotherapy for early TNBC patient care. The need for personalized medicine in oncology is widely accepted but translating this important concept into clinical practice has been challenging. Currently, the dominant platform for precision medicine utilizes genomics/sequencing-based assays to measure the expression and/or mutational profiles and then infer responses to targeted therapies; however, this approach benefits

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $1,198,662
Amendment $0
Amendment $583,104
Amendment $601,157
Amendment $0
Original award $644,226

Subawards

Subrecipient Amount Awarded
University Of Hawaii Validation of a novel 3D culture platform for TNBC treatment selection $32,469
Empiri, Inc. $182,210
The Univeristy Of Texas M.d. Anderson Cancer Center $159,861
The Univeristy Of Texas M.d. Anderson Cancer Center $111,155
University Of Hawaii $66,871
The Univeristy Of Texas M.d. Anderson Cancer Center $53,509
University Of Hawaii $154,260

Quick answers

Who received award R01CA271682?

R01CA271682 was awarded to The Methodist Hospital Research Institute by National Cancer Institute (National Institutes of Health) on September 20, 2022.

How much is award R01CA271682 worth?

$3,027,149 has been obligated on R01CA271682.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award